Endpoints livestream: Drugs and biomanufacturing in space with Varda CSO...
I am a classic low-information drugs-in-space skeptic. For years — years — I have been reading stories about how some tiny biotech, a research lab or a government agency has decided to send an...
View ArticlePrime Medicine CSO departs, reveals new funding; FDA lifts partial hold on...
Plus, news about OKYO Pharma, Modi Ventures and BriaCell Therapeutics: More changes at Prime Medicine: The biotech said Chief Scientific Officer Jeremy Duffield is leaving the company. It also...
View ArticleRFK replaces two top aides at HHS, including chief of staff
Robert F. Kennedy Jr. has replaced two key senior staffers at the top of the Department of Health and Human Services, including Chief of Staff Heather Flick. The change was confirmed by an agency...
View ArticlePureTech CEO leaves just one week after longtime chair steps down
PureTech Health CEO Bharatt Chowrira has stepped down, marking the second major departure at the hub-and-spoke biotech in recent weeks. Robert Lyne is taking over as interim CEO, according to a Wednesday
View ArticleBayer extends CEO Bill Anderson's contract through March 2029
Bayer is giving CEO Bill Anderson at least three more years to complete his ongoing transformation of the pharma and agriculture conglomerate. On Wednesday, the company said that it was extending...
View ArticleFDA questions efficacy of Otsuka's Rexulti combo for PTSD ahead of adcomm
The FDA is questioning whether Otsuka's Rexulti in combination with the antidepressant Zoloft has enough efficacy data to back an approval as a new treatment for post-traumatic stress disorder. The...
View ArticleFDA drugs center sees sharp rise in staff departures since January
Outside of the FDA-wide firings from April, the FDA's Center for Drug Evaluation and Research has had more than 380 staff departures from January through the end of June and just 18 new hires over ...
View ArticleWearable maker Whoop to fight FDA over blood pressure tracker
Whoop, the maker of a fitness and health tracker, is planning to fight the FDA’s attempt to stop the company from marketing a new blood pressure tracking feature. The FDA sent the Boston-based company...
View ArticlePfizer penicillin recall imperils syphilis antibiotic supply
A recent drug recall of Pfizer’s penicillin product has put the immediate supply of a key syphilis treatment at risk, according to the company and a coalition of public health officials addressing...
View ArticleSarepta lays off 500 people, adds black box warning to DMD therapy
Sarepta Therapeutics, dogged by safety concerns over its controversial Duchenne muscular dystrophy treatment, is cutting costs and laying off hundreds of workers as part of a large restructuring. The...
View ArticleNovartis ups income guidance, initiates $10B share buyback
Novartis slightly raised its full-year sales expectations even as its second-quarter sales just missed Wall Street analysts’ projections. Separate from its earnings, the Swiss drugmaker announced that...
View ArticleOpenEvidence raised $210M in GV's 'most competitive' deal
An AI search tool for doctors trained on medical journals just raised one of the largest venture rounds in health tech so far this year, as it leans into doctors’ growing comfortability ...
View ArticleSouth Korean drugmaker gets FDA warning over potential site contamination
Daewoo Pharmaceutical has received a warning letter from the FDA over the potential contamination of a substance known to cause lethal poisonings at its Busan, South Korea, manufacturing site. The
View ArticleBioNTech strategy chief Richardson to leave for 'new professional opportunities'
BioNTech's strategy chief Ryan Richardson is exiting the German company on Sept. 30 "to pursue new professional opportunities," the infectious disease and cancer drug developer said Thursday. His...
View ArticleMassive proteomics study reveals new clues about Alzheimer’s and rekindles...
Amyloid plaques and tau tangles are the most well-known protein structures associated with Alzheimer’s, but a new study bolsters the longstanding notion that there’s a lot more going on in the disease....
View ArticleThermo Fisher buys Sanofi factory; Amphastar Pharma quadruples HQ capacity
Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more. Thermo Fisher Scientific is acquiring a fill-finish and packaging...
View Article#IAS25: Q&A with International AIDS Society leader on HIV funding,...
KIGALI, RWANDA — Four decades into the HIV epidemic, the significance of conferences can easily be forgotten. But the International AIDS Society’s meeting on HIV Science this week in Rwanda will likely...
View ArticleUK government pledges “billions of pounds” for new research center in Essex
In its next move to boost the life sciences industry, the UK government is earmarking at least £250 million ($335 million) to help build a new research and development site called the National...
View ArticleNicox, Kowa make a deal for glaucoma drug; French techbio raises €15M
Plus, news about Clearside Biomedical: Nicox, Kowa ink licensing deal worth up to €191.5M: Kowa is gaining the exclusive rights to an experimental glaucoma treatment called NCX 470 in the US ...
View ArticleA health system takes an Amazon-like approach
Last week, Chicago-based Rush University System for Health debuted "Rush Connect," a subscription service that puts it toe to toe with other direct-to-consumer companies vying to be the first place ...
View Article